ArticleFrontiers in oncology2022
Optimal predictive probability designs for randomized biomarker-guided oncology trials.
Emily C Zabor et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it